Compugen Stock (NASDAQ:CGEN), Quotes and News Summary

Q: What sector and industry does Compugen (CGEN) operate in?

Compugen is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.

Compugen Stock (NASDAQ: CGEN) stock price, news, charts, stock research, profile.

Open	$1.880
Close	$1.880
Volume / Avg.	308.855K / 615.330K
Day Range	1.830 - 1.960
52 Wk Range	0.530 - 3.030
Market Cap	$171.898M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	2.42%
Days to Cover	7.16

Recent News

Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The S&P 500 also rose, gaining, 0.45% to 4,762.12.

Avi Kapoor

Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy program. Compugen shares jumped 204.1% to $2.22 on Tuesday.

Avi Kapoor

Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 150 points on Tuesday. The Dow traded up 0.46% to 37,476.21 while the NASDAQ rose 0.41% to 14,966.74. The S&P 500 also rose, gaining, 0.38% to 4,758.55.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Dec 23

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Compugen (CGEN) stock?

You can purchase shares of Compugen (NASDAQ: CGEN) through any online brokerage.

View our list of the best stock brokerages.

Who are Compugen's (CGEN) competitors?

There are no as such competitors for Compugen.

What is the target price for Compugen (CGEN) stock?

The latest price target for Compugen (NASDAQ: CGEN) was reported by Truist Securities on Friday, March 8, 2024. The analyst firm set a price target for 5.00 expecting CGEN to rise to within 12 months (a possible 160.42% upside). 8 analyst firms have reported ratings in the last year.

Current Stock Price for Compugen (CGEN)?

The stock price for Compugen (NASDAQ: CGEN) is $1.92 last updated April 17, 2024 at 7:02 PM EDT.

Does Compugen (CGEN) pay a dividend?

There are no upcoming dividends for Compugen.

When is Compugen (NASDAQ:CGEN) reporting earnings?

Compugen’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Compugen (CGEN) going to split?

There is no upcoming split for Compugen.

What sector and industry does Compugen (CGEN) operate in?

Compugen is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.